243 related articles for article (PubMed ID: 21155382)
1. Vendor qualification for pharmaceutical excipients--GMP requirements and approach.
Patel KT; Chotal NP
Pharmazie; 2010 Nov; 65(11):783-90. PubMed ID: 21155382
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical excipient development: the need for preclinical guidance.
Baldrick P
Regul Toxicol Pharmacol; 2000 Oct; 32(2):210-8. PubMed ID: 11067777
[TBL] [Abstract][Full Text] [Related]
3. Managing the microbiological quality of pharmaceutical excipients.
Cundell AM
PDA J Pharm Sci Technol; 2005; 59(6):381-95. PubMed ID: 16471425
[TBL] [Abstract][Full Text] [Related]
4. The safety of pharmaceutical excipients.
de Jong HJ
Therapie; 1999; 54(1):11-4. PubMed ID: 10216416
[TBL] [Abstract][Full Text] [Related]
5. A new approach to the safety assessment of pharmaceutical excipients. The Safety Committee of the International Pharmaceutical Excipients Council.
Steinberg M; Borzelleca JF; Enters EK; Kinoshita FK; Loper A; Mitchell DB; Tamulinas CB; Weiner ML
Regul Toxicol Pharmacol; 1996 Oct; 24(2 Pt 1):149-54. PubMed ID: 8933628
[TBL] [Abstract][Full Text] [Related]
6. Raw material considerations.
Lubiniecki AS; Shadle PJ
Dev Biol Stand; 1997; 91():65-72. PubMed ID: 9413684
[TBL] [Abstract][Full Text] [Related]
7. The evolution and challenges for the international harmonization of the regulation of pharmaceutical excipients in Taiwan.
Chang LC; Kang JJ; Gau CS
Regul Toxicol Pharmacol; 2015 Dec; 73(3):947-52. PubMed ID: 26387930
[TBL] [Abstract][Full Text] [Related]
8. Excipient variability and its impact on dosage form functionality.
Dave VS; Saoji SD; Raut NA; Haware RV
J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
[TBL] [Abstract][Full Text] [Related]
9. Managing Excipient Supplier Name and Address Changes in the Pharmaceutical Quality System.
Rolke R; Ramnarine E; Vinther A; Sawant A
PDA J Pharm Sci Technol; 2020; 74(2):286-288. PubMed ID: 32179712
[TBL] [Abstract][Full Text] [Related]
10. [An analysis of the pharmaceuticals market in Vietnam].
Simonet D
Sante; 2001; 11(3):155-60. PubMed ID: 11641078
[TBL] [Abstract][Full Text] [Related]
11. Advanced qualification of pharmaceutical excipient suppliers by multiple analytics and multivariate analysis combined.
Hertrampf A; Müller H; Menezes JC; Herdling T
Int J Pharm; 2015 Nov; 495(1):447-458. PubMed ID: 26342249
[TBL] [Abstract][Full Text] [Related]
12. Risk assessment of supply chain for pharmaceutical excipients with AHP-fuzzy comprehensive evaluation.
Li M; Du Y; Wang Q; Sun C; Ling X; Yu B; Tu J; Xiong Y
Drug Dev Ind Pharm; 2016; 42(4):676-84. PubMed ID: 26288999
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical GMP: past, present, and future--a review.
Patel KT; Chotai NP
Pharmazie; 2008 Apr; 63(4):251-5. PubMed ID: 18468382
[TBL] [Abstract][Full Text] [Related]
14. A PAT-based qualification of pharmaceutical excipients produced by batch or continuous processing.
Hertrampf A; Müller H; Menezes JC; Herdling T
J Pharm Biomed Anal; 2015 Oct; 114():208-15. PubMed ID: 26072012
[TBL] [Abstract][Full Text] [Related]
15. An Overview of Pharmaceutical Excipients: Safe or Not Safe?
Abrantes CG; Duarte D; Reis CP
J Pharm Sci; 2016 Jul; 105(7):2019-26. PubMed ID: 27262205
[TBL] [Abstract][Full Text] [Related]
16. Biopharmaceutical aspects and implications of excipient variability in drug product performance.
Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N
Eur J Pharm Biopharm; 2017 Feb; 111():1-15. PubMed ID: 27845182
[TBL] [Abstract][Full Text] [Related]
17. Application of instrumental colour measurement in development and quality control of drugs and pharmaceutical excipients.
Subert J; Cizmárik J
Pharmazie; 2008 May; 63(5):331-6. PubMed ID: 18557414
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical excipients. Adverse effects associated with inactive ingredients in drug products (Part I).
Golightly LK; Smolinske SS; Bennett ML; Sutherland EW; Rumack BH
Med Toxicol Adverse Drug Exp; 1988; 3(2):128-65. PubMed ID: 3287089
[TBL] [Abstract][Full Text] [Related]
19. Decision Support for Excipient Risk Assessment in Pharmaceutical Manufacturing.
Bejarano A; Hewa Nadungodage C; Wang F; Catlin AC; Hoag SW
AAPS PharmSciTech; 2019 Jun; 20(6):223. PubMed ID: 31214878
[TBL] [Abstract][Full Text] [Related]
20. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
World Health Organ Tech Rep Ser; 2003; 917():i-viii, 1-125, back cover. PubMed ID: 15024913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
